• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic’s billion-dollar buying spree

Medtronic’s billion-dollar buying spree

September 1, 2015 By Fink Densford

MedtronicMedtronic (NYSE:MDT) CEO Omar Ishrak has literally put his money where his mouth is since saying in early June that the world’s largest pure-play medtech maker would look for small-scale investments – $1.05 billion of that money, in fact.

That’s Fridley, Minn.-based Medtronic’s announced spend on M&A since June 5, when Ishrak said the company would turn its attention to snatching up early-stage firms.

“We’re going to look at early technologies, in the U.S. primarily, where there maybe opportunities which we haven’t been able to participate in to the degree that we’d like to, to create a long-term technology pipeline of early-stage technologies that we think can make a difference,” Ishrak said at the time, noting that Medtronic would still “opportunistically” look at larger buyouts, “but that’s a matter of our overall financial bandwidth and our management bandwidth.”

Medtronic has snatched up 5 different businesses since June:

  • $235 million for RF Surgical Systems and its RF-tag based device system designed to help prevent “never events” such as leaving a surgical sponge in a patient after surgery, using low radiofrequency signals to track the RF tags embedded in surgical gauze, sponges and towels. Medtronic said it plans to fold RF Surgical into its surgical solutions division of its minimally invasive technologies business.
  • $110 million to acquire Aptus Endosystems and its Heli-FX aortic securement device. After the purchase, Medtronic said it plans to continue Aptus’ ANCHOR registry for the Heli-FX device and to pursue approval for a <10mm infrarenal proximal neck indication for its Endurant stent graft with the use of the Heli-FX EndoAnchor system. Two versions of the device have won CE Mark approval in the European Union and FDA clerance.
  • $93 million for CardioInsight Technologies and its heart mapping ECVue, a non-invasive electrocardiographic  device that uses body surface electrical data and anatomical data to reconstruct and display 3-D maps and “other useful measures” of the heart’s electrical activity.
  • $458 million for Foundry incubator spinout Twelve Inc. and its transcatheter mitral valve implant. The deal calls for a $408 million payment once the deal closes, expected in October, and another $50 million pegged to CE Mark approval in the European Union for the Twelve TMVI device.
  • $150 million to acquire Medina Medical and its embolization coil, a self-expanding mesh designed to fill the inside of a brain aneurysm. The device won CE Mark approval in the European Union last year.

Filed Under: Mergers & Acquisitions Tagged With: Aptus EndoSystems Inc., CardioInsight Technologies Inc., Medina Medical, Medtronic, RF Surgical Systems, Twelve Inc.

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy